Coinpaper
2025-09-15 14:13:31

Helius Medical Bets Big on Solana with $500 Million Investment

Key Highlights Helius Medical invests $500M+ to make Solana a reserve asset Forward Industries buys $1.58B in Solana at $232 per coin Solana could surge to $250 by end of 2025, says analyst Helius Medical Technologies has launched a treasury strategy centered on Solana, planning to hold the cryptocurrency as a reserve using over $500 million raised through a private equity round targeting public equities. This move highlights growing institutional confidence in blockchain assets. Strategic Investments and Funding Partners Under the offering, investors received common shares or pre-funded warrants priced at $6,881 each, set to expire three years from issuance. If fully exercised, the transaction could exceed $750 million in total value. The funding round was led by Pantera Capital and Summer Capital, with additional participation from Big Brain Holdings, Avenir, SinoHope, FalconX, Arrington Capital, Animoca Brands, Aspen Digital, Borderless, Laser Digital, HashKey Capital, and Republic Digital. Following the deal’s expected close on September 18, 2025, Helius Medical plans to: Build an initial position in Solana and scale over 12–24 months Utilize ATM programs and other capital vehicles to deploy assets Explore staking, lending, and other DeFi instruments within Solana Maintain a conservative approach to risk management Forward Industries Makes a Massive Solana Bet Meanwhile, Forward Industries acquired 6.82 million SOL for roughly $1.58 billion, at an average price of $232 per coin, through open market and on-chain transactions. The press release noted this is the first time capital from a private equity round has been used to invest in public equity, with the round led by Galaxy Digital, Jump Crypto, and Multicoin Capital. MEXC Research chief analyst Sean Young predicts Solana could rise to $250 by the end of 2025, indicating strong optimism in the crypto market.

获取加密通讯
阅读免责声明 : 此处提供的所有内容我们的网站,超链接网站,相关应用程序,论坛,博客,社交媒体帐户和其他平台(“网站”)仅供您提供一般信息,从第三方采购。 我们不对与我们的内容有任何形式的保证,包括但不限于准确性和更新性。 我们提供的内容中没有任何内容构成财务建议,法律建议或任何其他形式的建议,以满足您对任何目的的特定依赖。 任何使用或依赖我们的内容完全由您自行承担风险和自由裁量权。 在依赖它们之前,您应该进行自己的研究,审查,分析和验证我们的内容。 交易是一项高风险的活动,可能导致重大损失,因此请在做出任何决定之前咨询您的财务顾问。 我们网站上的任何内容均不构成招揽或要约